These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33295153)

  • 1. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
    Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
    Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
    Vera-Llonch M; Oster G; Hagiwara M; Sonis S
    Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.
    Brzozowska A; Mlak R; Gołębiowski P; Małecka-Massalska T
    Clin Transl Oncol; 2019 May; 21(5):615-620. PubMed ID: 30327938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glutamine: Is there a role in the amelioration of radiation-induced mucositis? A prospective case-control study at a tertiary care centre in North India.
    Fatima K; Andleeb A; Nasreen S; Sofi MA; Najmi AM; Qadri SK; Ryhan R; Roohi S; Afroz F; Khan NA
    J Cancer Res Ther; 2024 Apr; 20(3):858-862. PubMed ID: 38261438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
    Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
    J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
    Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
    Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
    JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
    Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
    Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Invernizzi C; Da Silva Ribeiro Mota A; Barbe C; Bouazzi L; Marques O; Munschi L; Marchand-Crety C; Jacquin N; Dubernard X; Beddok A; Lasset C; Assouly N; Vignot S; Brenet E
    Oral Oncol; 2024 Jun; 153():106833. PubMed ID: 38729039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
    Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
    Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
    Blakaj A; Bonomi M; Gamez ME; Blakaj DM
    Oral Oncol; 2019 Aug; 95():29-34. PubMed ID: 31345391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
    Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
    Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.